Skip to main content
Premium Trial:

Request an Annual Quote

Morningstar Gives Illumina a BB+ Credit Rating

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment research firm Morningstar has initiated a credit rating for Illumina of BB+, which it said reflects its negative view of the genetic analysis instrument business.

Morningstar said that although Illumina's financial position "looks solid," its rating "recognizes the fundamental advantages of competing in this industry." It also used Affymetrix's "recent downfall" in market position as a cautionary note for Illumina's creditors.

"While Illumina currently is dominating its target niches, particularly in sequencing, we believe it is very difficult to sustain competitive advantages in this market for the long run," said Morningstar. "Users of genetic analysis tools gravitate toward the best throughput … and easiest to use options. If new entrants or existing competitors eventually surpass Illumina in those characteristics, demand for Illumina's tools could decline or profit-damaging pricing pressure could ensue in this business."

It also said that Illumina's currently solid financial position — which includes an estimated $748 million in cash and short-term investments versus $390 million in outstanding principal on its convertible debt issue maturing in February 2014 — could take a hit if the firm is forced to spend big on an acquisition.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.